State Street SPDR S&P Health Care Services ETF
XHS
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 1 Iron Street Boston MA United States of America 2210
- IPO Date
- Sep 29, 2011
- CIK
- 0001064642
- Website
- ssga.com
- Similar Companies
- Business
- SPDR S&P Health Care Services ETF (XHS) is an exchange-traded fund that seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Health Care Services Select Industry Index. The fund employs an equal-weighted indexing strategy focused on U.S. companies in the health care services sub-industry as defined by the Global Industry Classification Standard (GICS); its portfolio comprises approximately 61 equity holdings, including providers of health care services such as laboratory and diagnostic services (e.g., Guardant Health Inc., NeoGenomics Inc.), health care facilities and operators (e.g., HCA Healthcare Inc., Universal Health Services Inc., Select Medical Holdings Corp.), health care distributors (e.g., Cardinal Health Inc., McKesson Corp, Cencora Inc.), managed care providers (e.g., Centene Corp), home health care services (e.g., Addus HomeCare Corp, Brookdale Senior Living Inc.), and specialized health care technology and services (e.g., Progyny Inc., HealthEquity Inc., RadNet Inc.). Launched on September 28, 2011, and domiciled in the United States, XHS is issued and managed by State Street Global Advisors and primarily targets institutional and retail investors seeking concentrated exposure to the domestic health care services sector. The fund operates exclusively in U.S. equity markets with a net expense ratio of 0.35% and total assets under management of approximately $73 million to $88 million. As an established product with no reported recent acquisitions, partnerships, funding rounds, name changes, or major strategic shifts within the last 1-2 years, XHS continues to track its benchmark index through quarterly rebalancing while maintaining its focus on equal-weighted holdings across health care services providers.